Skip to main content
Year archive

Hua Medicine — 2019 filings

All 40 regulatory filings released by Hua Medicine (2552) in 2019, sourced directly from the official regulator.

40 Filings
2019 Period
2019 filings (40)
Filing Released Lang
CHANGE OF COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE
Board/Management Information
2019-12-31 English
SUPPLEMENTAL ANNOUNCEMENT - DISCLOSEABLE TRANSACTION IN RELATION TO TENANCY AGREEMENT
Regulatory Filings
2019-12-05 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2019-12-04 English
DISCLOSEABLE TRANSACTION IN RELATION TO TENANCY AGREEMENT
Regulatory Filings
2019-12-03 English
GRANT OF SHARE OPTIONS
Capital/Financing Update
2019-11-14 English
GRANT OF SHARE OPTIONS
Share Issue/Capital Change
2019-11-14 English
BUSINESS UPDATE ON FIRST PHASE III MONOTHERAPY TRIAL OF DORZAGLIATIN - ANNOUNCEMENT OF POTENTIAL INSIDE INFORMATION
Regulatory Filings
2019-11-11 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2019-11-06 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2019-10-04 English
INTERIM REPORT 2019
Interim / Quarterly Report
2019-09-26 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2019-09-04 English
GRANT OF SHARE OPTIONS
Share Issue/Capital Change
2019-09-02 English
BUSINESS UPDATE - COMPLETION OF PATIENT ENROLLMENT FOR PHASE III COMBINATION WITH METFORMIN TRIAL OF DORZAGLIATIN
Regulatory Filings
2019-08-30 English
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2019
Regulatory Filings
2019-08-23 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2019
Interim / Quarterly Report
2019-08-15 English
Monthly Return of Equity Issuer on Movements in Securities
Capital/Financing Update
2019-08-05 English
Date of Board Meeting
Regulatory Filings
2019-08-05 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2019-07-03 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 24, 2019
Declaration of Voting Results & Voting Rights Announcements
2019-06-24 English
CHANGE OF ADDRESS OF HONG KONG BRANCH SHARE REGISTRAR AND TRANSFER OFFICE
Regulatory Filings
2019-06-24 English
CLARIFICATION ANNOUNCEMENT ON NOTICE OF ANNUAL GENERAL MEETING, CIRCULAR AND PROXY FORM
AGM Information
2019-06-14 English
REVISED FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON MONDAY, JUNE 24, 2019
AGM Information
2019-06-14 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2019-06-06 English
VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE ON PRODUCT PIPELINE FOR DORZAGLIATIN
Regulatory Filings
2019-06-05 English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON MONDAY, JUNE 24, 2019
AGM Information
2019-05-16 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2019-05-16 English
(I) PROPOSED RE-ELECTION OF RETIRING DIRECTORS&#x3b; (II) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES&#x3b; (III) GRANT OF SHARE OPTIONS&#x3b; AND (IV) NOTICE O
AGM Information
2019-05-16 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2019-05-06 English
Annual Report 2018
Annual Report
2019-04-29 English
VOLUNTARY ANNOUNCEMENT - FIRST COMBINATION STUDY OF DORZAGLIATIN WITH A SGLT-2 INHIBITOR IN THE UNITED STATES
Regulatory Filings
2019-04-23 English
Monthly Return of Equity Issuer on Movements in Securities
Major Shareholding Notification
2019-04-02 English
GRANT OF SHARE OPTIONS
Share Issue/Capital Change
2019-03-11 English
CHANGE OF COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE
Board/Management Information
2019-03-07 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2018
Annual Report
2019-03-07 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2019-03-04 English
BUSINESS UPDATE - COMPLETION OF PATIENT ENROLLMENT FOR PHASE III MONOTHERAPY TRIAL OF DORZAGLIATIN
Capital/Financing Update
2019-03-01 English
Date of Board Meeting
Regulatory Filings
2019-02-25 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2019-02-01 English
VOLUNTARY ANNOUNCEMENT - FIRST COMBINATION STUDY OF DORZAGLIATIN WITH A DPP-4 INHIBITOR IN THE UNITED STATES
Regulatory Filings
2019-02-01 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2019-01-02 English